Loading
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (1 ops.)
Latest filing published 23 Jul 2021 for ALEXION PHARMACEUTICALS INC.
Filing timeline
BuySaleJohn J. Orloff
Insider track record
Disclosed buys
0
Disclosed sells
1
Signal history
John J. Orloff: trading record in brief
John J. Orloff (senior executive) discloses dealings in 2 companies, chiefly Alexion Pharmaceuticals Inc and Baxalta Inc. Between 1 July 2015 and 21 July 2021, the trades on record add up to 24 filings.
The open-market record consists of 1 sale worth €213k, with no purchase. The rest of the record consists of 20 share grants.
Most recently, on 23 July 2021, the filings show a transaction in Alexion Pharmaceuticals Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 3 days. For comparison, the SEC allows two business days to file a Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to John J. Orloff
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations24 total
146,511 shares0Common Stock, par value $.0001 per shareSEC:0000899866-21-000062:0
29,501 shares0Common Stock, par value $.0001 per shareSEC:0000899866-21-000054:1
30,643 shares0Common Stock, par value $.0001 per shareSEC:0000899866-21-000054:0
1,957 shares@ US$177.00100.0% of flowCommon Stock, par value $.0001 per shareSEC:0000899866-21-000050:0
24,473 shares0Common Stock, par value $.0001 per shareSEC:0000899866-21-000023:0
40,677 shares0Common Stock, par value $.0001 per shareSEC:0000899866-20-000093:0
18,134 shares@ US$157.9668.0% of flowCommon Stock, par value $.0001 per shareSEC:0000899866-20-000093:1
3,261 shares@ US$157.9612.2% of flowCommon Stock, par value $.0001 per shareSEC:0000899866-20-000093:2
40 shares@ US$93.530.1% of flowCommon Stock, par value $.0001 per shareSEC:0000899866-20-000093:3
2,784 shares@ US$114.618.1% of flowCommon Stock, par value $.0001 per shareSEC:0000899866-20-000063:0
1,396 shares@ US$90.543.3% of flowCommon Stock, par value $.0001 per shareSEC:0000899866-20-000023:1
38 shares@ US$93.860.1% of flowCommon Stock, par value $.0001 per shareSEC:0000899866-20-000023:2
10,880 shares0Common Stock, par value $.0001 per shareSEC:0000899866-20-000023:0
2,786 shares@ US$118.617.2% of flowCommon Stock, par value $.0001 per shareSEC:0000899866-19-000077:0
9,428 shares0Common Stock, par value $.0001 per shareSEC:0000899866-19-000048:0
675 shares@ US$132.921.9% of flowCommon Stock, par value $.0001 per shareSEC:0000899866-19-000041:0
34 shares@ US$93.010.1% of flowCommon Stock, par value $.0001 per shareSEC:0000899866-19-000041:1
2,115 shares@ US$118.535.2% of flowCommon Stock, par value $.0001 per shareSEC:0000899866-18-000101:0
8,940 shares0Common Stock, par value $.0001 per shareSEC:0000899866-18-000059:0
24,965 shares0Common Stock, par value $.0001 per shareSEC:0000899866-17-000133:0
96,384 sharesCommon Stock, par value $0.01 per shareSEC:0000899243-16-021959:0
55,951 sharesCommon Stock, par value $0.01 per shareSEC:0000899243-16-015439:0
1,408 shares@ US$39.30100.0% of flowCommon Stock, par value $0.01 per shareSEC:0000899243-16-015439:1
40,521 shares0Common Stock, par value $0.01 per shareSEC:0000899243-15-000632:0
24 of 24 declarations
